Thomas Catinazzo - Jan 28, 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Jan 28, 2025
Transactions value $
-$268,339
Form type
4
Date filed
1/30/2025, 09:10 PM
Previous filing
Jan 14, 2025
Next filing
Mar 31, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$156K -33.8K -11.28% $4.63 265K Jan 28, 2025 Direct F1, F2
transaction RLAY Common Stock Sale -$10.6K -2.28K -0.86% $4.63 263K Jan 28, 2025 Direct F2, F3
transaction RLAY Common Stock Award $0 +139K +52.87% $0.00 402K Jan 28, 2025 Direct F4, F5
transaction RLAY Common Stock Sale -$9.6K -2.11K -0.52% $4.55 400K Jan 29, 2025 Direct F3, F5
transaction RLAY Common Stock Sale -$91.9K -20.8K -5.19% $4.42 379K Jan 30, 2025 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 105,723 shares of restricted stock units ("RSUs") on January 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 185,775 shares underlying RSUs.
F3 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.
F4 Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F5 Includes 324,916 shares underlying RSUs.
F6 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 69,570 shares of RSUs on January 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F7 Includes 255,346 shares underlying RSUs.